William A. Wegener
Impact in
- Oncology top 1%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 33
- Radiopharmaceutical Chemistry and Applications 32
-
- Lymphoma Diagnosis and Treatment 34
- Co-authors
- David M. Goldenberg (90 shared papers)Robert M. Sharkey (29 shared papers)Linda T. Vahdat (10 shared papers)Aditya Bardia (16 shared papers)Heather Horne (28 shared papers)Gerd R Burmester (3 shared papers)Nick Teoh (16 shared papers)John P. Leonard (8 shared papers)
- Journals
- Journal of Clinical Oncology (32 papers)Blood (18 papers)Cancer Research (7 papers)Biopolymers (5 papers)Cancer (5 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
William A. Wegener
124 papers receiving 4.7k citations
William A. Wegener's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.9k
- Radiology, Nuclear Medicine and Imaging 1.6k
- Genetics 607
- Pathology and Forensic Medicine 1.0k
- Immunology 811
Countries citing papers authored by William A. Wegener
This map shows the geographic impact of William A. Wegener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Wegener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Wegener more than expected).
Fields of papers citing papers by William A. Wegener
This network shows the impact of papers produced by William A. Wegener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Wegener. The network helps show where William A. Wegener may publish in the future.
Co-authors
The 25 scholars most cited alongside William A. Wegener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 624 |
| 2 | 2015 | 261 | |
| 3 | 2006 | 242 | |
| 4 | 2017 | 193 | |
| 5 | 2003 | 192 | |
| 6 | 2006 | 191 | |
| 7 | 2004 | 184 | |
| 8 | 2008 | 147 | |
| 9 | 2017 | 147 | |
| 10 | 2005 | 133 | |
| 11 | 2009 | 126 | |
| 12 | 2006 | 116 | |
| 13 | 2020 | 114 | |
| 14 | 2005 | 100 | |
| 15 | 2013 | 98 | |
| 16 | 2013 | 94 | |
| 17 | 2017 | 84 | |
| 18 | 2008 | 82 | |
| 19 | 2010 | 78 | |
| 20 | 2015 | 71 |
About William A. Wegener
William A. Wegener is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 125 papers that have together received 4.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (34 papers), Monoclonal and Polyclonal Antibodies Research (33 papers), Radiopharmaceutical Chemistry and Applications (32 papers), HER2/EGFR in Cancer Research (19 papers), Chronic Lymphocytic Leukemia Research (14 papers), Cancer Treatment and Pharmacology (9 papers), CAR-T cell therapy research (6 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Oncology (1.9k citations), Radiology, Nuclear Medicine and Imaging (1.6k citations), Genetics (607 citations), Pathology and Forensic Medicine (1.0k citations) and Immunology (811 citations). William A. Wegener has collaborated with scholars based in United States, France and Germany. Frequent co-authors include David M. Goldenberg, Robert M. Sharkey, Linda T. Vahdat, Aditya Bardia, Heather Horne, Gerd R Burmester, Nick Teoh, John P. Leonard, Morton Coleman and Michael J. Guarino. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Biopolymers and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.